Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep233 | Bone & Osteoporosis | ECE2017

The effect of mechanical assisted squat exercise on pulmonary function, muscle mass and function with or without sarcopenia

Jeon YunKyung , Shin MyungJun , Kim InJoo , Kim BoHyun , Shin YongBeom

Introduction: Sarcopenia is a geriatric syndrome that causes age-related changes to muscle mass and function. Lung function is reduced in elderly patients with sarcopenia. We explored whether a mechanically assisted squat exercise improved muscle function and mass and pulmonary function in community-dwelling elderly women with or without sarcopenia.Methods: Participants were recruited via posters or the websites of regional health centers. In total, 76 c...

ea0049ep697 | Obesity | ECE2017

An assessment of the relationship between abdominal obesity and the severity of upper extremity lymphedema

Jeon YunKyung , Shin MyungJun , Shin YongBeom , Kim InJoo , Kim BoHyen

Abstract: Obesity is one of the well-known initiating and aggravating factor of lymphedema. BMI is typically used to define obesity, but in Asian populations, health risks are elevated at lower BMI levels and abdominal fat may be a better obesity metric. Thus, we assessed the potential association between abdominal obesity and lymphedema severity in postoperative breast cancer patients. Thirty-three women with breast cancer-related lymphedema participated in this study. Arm ci...

ea0081p161 | Pituitary and Neuroendocrinology | ECE2022

The prevalence of metabolic syndrome in patients with hyperprolactinemia

Kim Eunheui , Im Myungsoo , Ryang Soree , Yi Wook , Kim Injoo

Objective: Hyperprolactinemia might be related to weight gain, metabolic syndrome, and insulin resistance. The aim of this study was to evaluate that patients with hyperprolactinemia were higher prevalence of metabolic syndrome than civilian population.Methods: From 1st Jan. 1998 to 17th Nov. 2017, 950 patients newly diagnosed hyperprolactinemia in Pusan National University Hospital, Pusan, South Korea, were selected to enroll in a study conducted on hyp...

ea0070aep167 | Bone and Calcium | ECE2020

The trabecular bone score predicts vertebral fragility fractures and decrease in volumetric bone mineral density in postmenopausal women

Kim Keunyoung , Kim Injoo , Pak Kyoungjune , Kim Eunheui , Kyung Jeon Yun

Background: Osteoporosis frequently occurs in elderly people and is commonly associated with fall and fractures which leads the increase of morbidity and mortality. Therefore, precise prediction of osteoporotic fracture is important in clinical setting. The objective of this study was to investigate the association between baseline compression fracture and trabecular bone score (TBS) and was to assess the ability of TBS to predict vertebral fragility fracture and changes of vo...

ea0073aep194 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Hedonic rating of sucrose is sub-regionally associated with striatal dopamine transporter in humans

Pak Kyoungjune , Seo Seongho , Lee Myung Jun , Kim Keunyoung , Suh Sunghwan , Lee Jeehyun , Kim Injoo

Eating behavior is determined by both homeostatic and hedonic values. We investigated the association of hedonic value with striatal dopamine transporter (DAT) availability sub-regionally. An intravenous bolus injection of 18F-FP-CIT was administered after the infusion of glucose or placebo, and the emission data were acquired over 90 mins. DAT availability, binding potential (BPND), were measured via the simplified reference tissue method. Subje...

ea0090p335 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Dapagliflozin Improves Glycemic control and Liver Function with Body Weight Loss as Add-on therapy to Metformin Plus Evogliptin: A 24-week, Randomized, Double-blind, Clinical Trial

Jeong In-Kyung , Mook Choi Kyung , Ah Han Kyung , Kim Kyoung-Ah , kim injoo , jin Han Seung , Wan Lee Byung , Lee Won-Young , Jib Yoo Soon

Background and aims: The efficacy and safety of dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus (T2DM) and inadequate glycemic control with evogliptin and metformin combinations was investigated.Materials and methods: Patients with HbA1c of 7.0% to 10.5% receiving evogliptin 5mg and metformin ≥1000 mg were randomized to receive dapagliflozin 10 mg/day (n=99) or placebo (n=99) for 24 weeks. The primary end...